Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSK44459 in moderate to severe plaque psoriasis
NCT07150988Phase 2Not yet recruiting
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Sep 2025
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HSK44459 in plaque psoriasis, sponsored by Haisco Pharmaceutical Group Co., Ltd.. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
HSK44459
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT07150988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07150988.